MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
7.04
-0.01 (-0.14%)
At close: Dec 22, 2025, 4:00 PM EST
7.04
0.00 (0.00%)
After-hours: Dec 22, 2025, 4:00 PM EST
MiMedx Group Stock Forecast
Stock Price Forecast
The 2 analysts that cover MiMedx Group stock have a consensus rating of "Buy" and an average price target of $11, which forecasts a 56.25% increase in the stock price over the next year. The lowest target is $10 and the highest is $12.
Price Target: $11 (+56.25%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for MiMedx Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +42.05% | Dec 17, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $11 → $12 | Buy | Maintains | $11 → $12 | +70.45% | Jul 31, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $11 | Buy | Reiterates | $11 | +56.25% | Jul 15, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $13 | Buy | Reiterates | $13 | +84.66% | Feb 27, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $11 | Buy | Reiterates | $11 | +56.25% | Aug 1, 2024 |
Financial Forecast
Revenue This Year
415.63M
from 348.88M
Increased by 19.13%
Revenue Next Year
424.40M
from 415.63M
Increased by 2.11%
EPS This Year
0.43
from 0.28
Increased by 51.47%
EPS Next Year
0.25
from 0.43
Decreased by -41.67%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 432.2M | 488.2M | ||||
| Avg | 415.6M | 424.4M | ||||
| Low | 392.0M | 370.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 23.9% | 17.4% | ||||
| Avg | 19.1% | 2.1% | ||||
| Low | 12.4% | -10.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.46 | 0.30 | |
| Avg | 0.43 | 0.25 | |
| Low | 0.39 | 0.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 63.4% | -28.9% | |
| Avg | 51.5% | -41.7% | |
| Low | 38.6% | -54.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.